Donna Young

Donna Young

@DonnaYoungDC

Followers7.9K
Following2K

All things Washington for pharma/biotech, health care & science news - 'The pharma diviner' - Senior Reporter, S&P Global News

Washington
Joined on May 29, 2012

Statistics

We looked inside some of the tweets by @DonnaYoungDC and here's what we found interesting.

Inside 100 Tweets

Time between tweets:
a minute
Average replies
1
Average retweets
0
Average likes
0
Tweets with photos
0 / 100
Tweets with videos
0 / 100
Tweets with links
0 / 100

Recommended

Check out our new cool site: http://www.tumgir.com

Last Seen Profiles

@anavel95@anavel95
@hanzaleh993@hanzaleh993
@ad3pt14@ad3pt14
@marielawho@marielawho
@AlHabibi5330@AlHabibi5330
@Gloria_Ann_0630@Gloria_Ann_0630
@DJAMSbroncos@DJAMSbroncos
@AlexHob89@AlexHob89
@Mi_guz_@Mi_guz_
@Naif_na_0@Naif_na_0
@Elizabe80167178@Elizabe80167178
@demonconfigs@demonconfigs
@mariko_kodaki@mariko_kodaki
@coppiaxlroma@coppiaxlroma
@moelsagher@moelsagher
@417BH@417BH

Quoted @DonnaYoungDC

.@SGottliebFDA on sesame as allergen: We're concerned about instance of allergies & severity. It appears based on info we have now it meets objective criteria There is sufficient concern FDA is going to continue to move forward. Confident it will go forward #GottliebReflects #FDA

There goes Sesame Street.

0
1
2

Great job @annaedney on questioning @SGottliebFDA today #GottliebReflects #FDA #pharma #biotech

0
1
1

.@SGottliebFDA ends by explaining he's got a few pairs of his popular skeletons socks Says @NYTimes objectified his socks. #GottliebReflects #FDA #pharma #biotech

1
0
0

.@SGottliebFDA on sesame as allergen: We're concerned about instance of allergies & severity. It appears based on info we have now it meets objective criteria There is sufficient concern FDA is going to continue to move forward. Confident it will go forward #GottliebReflects #FDA

1
1
0

.@SGottliebFDA on Office of Women's Health acting director: I feel like we are leaving office good shape. #GottliebReflects #FDA #pharma #biotech

1
0
0

.@SGottliebFDA on 12yrs #biotech exclusivity #biosimilars: We have robust investment in #pharma sector. Whatever we did we did the right thing We got a lot of things right Still problems affordability. A lot of market failures aren't related to patent terms. #GottliebReflects

1
0
0

.@SGottliebFDA: Nicotine not a completely benign substance, but not what causes death w/ tobacco use. #GottliebReflects #FDA #pharma #biotech #vaping #ecigarettes #tobacco

1
0
0

.@SGottliebFDA: We're capturing an exploding epidemic right now. Notes #OpioidEpidemic started w/ legal Rx. #GottliebReflects #FDA #pharma #biotech #vaping #ecigarettes #Juul

1
2
1

.@SGottliebFDA: Nicotine not what is causing death. It's the products of combustion. We've been clear on that. What changed our policy is the explosion in nicotine use by children #GottliebReflects #FDA #pharma #biotech #tobacco #Juul #vaping

1
2
1

.@SGottliebFDA notes majority of new molecular entity drugs in 2018 were targeting #rarediseases #GottliebReflects #FDA #pharma #biotech

1
0
0

.@SGottliebFDA: There's been a lot of innovations in trial designs for drugs targeting #RareDiseases. FY19 budget had natural history models $; allocated a lot of resources to that. Overall, it's had a tangible impact. #GottliebReflects #FDA #pharma #biotech

1
1
0

.@SGottliebFDA: If we could have a model on how dogs metabolize drugs, won't have to use dogs in studies in future. Dogs being used in tests will be put up for adoption. Have to make legal determination if can adopt gov property #GottliebReflects #FDA #pharma #biotech

1
0
0

.@SGottliebFDA on if #FDA should be independent agency: I'll reserve my judgment for that for about 2 ½ weeks & then will opine on it. There is a very unique aspect to the work that FDA does. #GottliebReflects #pharma #biotech

1
0
0

And noting this is on vacation (children's spring break). Not as a job (: for @SGottliebFDA heading to Disney World [wanted to make sure no one confused that. No, he's not going to be a $DIS exec ... though who knows what the future brings] #GottliebReflects #pharma #biotech

1
0
0

What's @SGottliebFDA doing after he leaves #FDA? He's going to @Disney World. #GottliebReflects #pharma #biotech $DIS

1
0
2

.@SGottliebFDA: I've made no secret I'm a big fan of Ned Sharpless. I think he's going to be embraced by the professional staff. I feel very confident. Ultimately up to @SecAzar & Trump what they want to do w/ that slot. #GottliebReflects #FDA #pharma #biotech

1
0
1

.@SGottliebFDA on his Jan. 3 tweet denying he was leaving: There wasn't more intrigue to the story Goals in January was stay until 2 year mark. But that got difficult on commute. #GottliebReflects #FDA #pharma #biotech

1
0
0

.@SGottliebFDA says April 5 is his last day. Staying to testify on April 3 on #FDA budget. #GottliebReflects #FDA #pharma

1
0
0

.@SGottliebFDA on #biosimilars: As doctors gain more comfort & more developed, I think there will be more clinical comfort. It hasn't surprised me that it has been slow to develop. Optimistic. Biggest impediment is the commercial impediment. #GottliebReflects #FDA #pharma

1
0
1

.@SGottliebFDA: #pharma amps up the royalties on the eve of #biosimilars. #GottliebReflects #FDA #pharma #biotech

1
0
0
Next Page